MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Neogen Corporation ROE Ratio 2011-2026 | NEOG
Annual ROE Ratio Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -52.72 | -0.3 | -0.73 | 5.44 | 7.24 | 8.2 | 9.43 | 11.27 | 9.29 | 9.05 | 9.55 | 9.19 | 10.53 | 10.29 | 12.11 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.11 | -52.72 | 3.86 |
Quarterly ROE Ratio Neogen Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.13 | -16.2 | -17.91 | -17.97 | -17.63 | -0.64 | -0.13 | 0.13 | 0.46 | -0.78 | -0.5 | -4.62 | -4.26 | -1.67 | -0.26 | 7.19 | 8.16 | 8.95 | 9.07 | 7.94 | 8.06 | 8.37 | 8.48 | 8.84 | 9.42 | 9.73 | 10.13 | 10.45 | 10.87 | 11.49 | 11.32 | 12.08 | 11.88 | 11.16 | 11.09 | 10.22 | 10.14 | 9.99 | 10.16 | 9.99 | 10.2 | 10.17 | 10.43 | 10.39 | 10.64 | 10.44 | 10.54 | 10.4 | 10.54 | 11.19 | 11.23 | 11.93 | 11.96 | 11.69 | 11.81 | 11.49 | 11.6 | 3.06 | 2.78 | 3.18 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.08 | -17.97 | 5.98 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 114.25 | -1.07 % | $ 34.7 B |  USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.64 | 3.53 % | $ 85.7 K | USA |
|
Biodesix
BDSX
|
-205.65 | $ 15.55 | 3.19 % | $ 2.02 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
-59.42 | $ 1.2 | -0.03 % | $ 6.53 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.5 | 1.85 % | $ 178 M |  China |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 18.32 | 0.05 % | $ 976 M | USA |
 |
Celcuity
CELC
|
-176.06 | $ 113.8 | 1.04 % | $ 5.32 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 168.44 | -3.13 % | $ 8.35 B | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.85 | 0.04 % | $ 690 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 197.89 | 0.37 % | $ 22 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 190.62 | -0.26 % | $ 136 B | USA |
 |
DexCom
DXCM
|
30.46 | $ 62.7 | 0.76 % | $ 24.5 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.8 | -0.15 % | $ 508 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
419.18 | $ 92.35 | -1.58 % | $ 11.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 110.38 | -3.34 % | $ 9.1 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 127.63 | 0.2 % | $ 20.3 B | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 168.24 | -2.9 % | $ 28.9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 274.94 | 0.41 % | $ 22.9 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 76.0 | -0.14 % | $ 5.13 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 485.89 | -2.5 % | $ 14 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 258.2 | -0.3 % | $ 25.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.84 | 1.79 % | $ 448 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 4.69 | - | $ 3.69 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.06 | 0.75 % | $ 1.03 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.35 | 1.11 % | $ 388 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 207.01 | -0.46 % | $ 20.4 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.36 | 1.49 % | $ 408 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 27.09 | -0.07 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
-2.49 | $ 25.23 | -1.29 % | $ 40.5 M | USA |
 |
Personalis
PSNL
|
-40.05 | $ 6.63 | 0.76 % | $ 393 M | USA |
 |
RadNet
RDNT
|
-1.71 | $ 55.12 | 0.6 % | $ 4.14 B | USA |